nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—Chills—Erlotinib—kidney cancer	0.00327	0.00332	CcSEcCtD
Vildagliptin—Flatulence—Everolimus—kidney cancer	0.00324	0.00329	CcSEcCtD
Vildagliptin—Connective tissue disorder—Sorafenib—kidney cancer	0.00322	0.00327	CcSEcCtD
Vildagliptin—Malnutrition—Erlotinib—kidney cancer	0.00317	0.00322	CcSEcCtD
Vildagliptin—Hepatitis—Sunitinib—kidney cancer	0.00315	0.0032	CcSEcCtD
Vildagliptin—Hypoglycaemia—Paclitaxel—kidney cancer	0.00314	0.00318	CcSEcCtD
Vildagliptin—Flatulence—Erlotinib—kidney cancer	0.00313	0.00317	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00311	0.00316	CcSEcCtD
Vildagliptin—Fatigue—Temsirolimus—kidney cancer	0.00311	0.00315	CcSEcCtD
Vildagliptin—Oedema peripheral—Sunitinib—kidney cancer	0.00311	0.00315	CcSEcCtD
Vildagliptin—Connective tissue disorder—Sunitinib—kidney cancer	0.0031	0.00314	CcSEcCtD
Vildagliptin—Blister—Doxorubicin—kidney cancer	0.0031	0.00314	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Pazopanib—kidney cancer	0.0031	0.00314	CcSEcCtD
Vildagliptin—Constipation—Temsirolimus—kidney cancer	0.00308	0.00313	CcSEcCtD
Vildagliptin—Tremor—Everolimus—kidney cancer	0.00308	0.00312	CcSEcCtD
Vildagliptin—Angioedema—Everolimus—kidney cancer	0.003	0.00305	CcSEcCtD
Vildagliptin—Hepatitis—Dactinomycin—kidney cancer	0.00299	0.00303	CcSEcCtD
Vildagliptin—Angiopathy—Sorafenib—kidney cancer	0.00297	0.00302	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Pazopanib—kidney cancer	0.00293	0.00298	CcSEcCtD
Vildagliptin—Fatigue—Pazopanib—kidney cancer	0.00293	0.00297	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Capecitabine—kidney cancer	0.00288	0.00292	CcSEcCtD
Vildagliptin—Angiopathy—Sunitinib—kidney cancer	0.00286	0.0029	CcSEcCtD
Vildagliptin—Malnutrition—Sorafenib—kidney cancer	0.00285	0.00289	CcSEcCtD
Vildagliptin—Chills—Sunitinib—kidney cancer	0.00283	0.00287	CcSEcCtD
Vildagliptin—Liver function test abnormal—Paclitaxel—kidney cancer	0.00283	0.00287	CcSEcCtD
Vildagliptin—Arthralgia—Everolimus—kidney cancer	0.0028	0.00284	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.00278	0.00282	CcSEcCtD
Vildagliptin—Malnutrition—Sunitinib—kidney cancer	0.00275	0.00278	CcSEcCtD
Vildagliptin—Nasopharyngitis—Paclitaxel—kidney cancer	0.00274	0.00278	CcSEcCtD
Vildagliptin—DPP4—Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)—PAX6—kidney cancer	0.00271	0.191	CbGpPWpGaD
Vildagliptin—Flatulence—Sunitinib—kidney cancer	0.00271	0.00274	CcSEcCtD
Vildagliptin—Arthralgia—Erlotinib—kidney cancer	0.0027	0.00274	CcSEcCtD
Vildagliptin—Oedema—Everolimus—kidney cancer	0.00268	0.00272	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.00268	0.00272	CcSEcCtD
Vildagliptin—Chills—Dactinomycin—kidney cancer	0.00268	0.00272	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Gemcitabine—kidney cancer	0.00267	0.0027	CcSEcCtD
Vildagliptin—Infection—Everolimus—kidney cancer	0.00267	0.0027	CcSEcCtD
Vildagliptin—Nervous system disorder—Everolimus—kidney cancer	0.00263	0.00267	CcSEcCtD
Vildagliptin—Dermatitis bullous—Capecitabine—kidney cancer	0.00263	0.00267	CcSEcCtD
Vildagliptin—Connective tissue disorder—Vincristine—kidney cancer	0.00262	0.00266	CcSEcCtD
Vildagliptin—Angioedema—Sorafenib—kidney cancer	0.00261	0.00264	CcSEcCtD
Vildagliptin—Skin disorder—Everolimus—kidney cancer	0.00261	0.00264	CcSEcCtD
Vildagliptin—Pancreatitis—Paclitaxel—kidney cancer	0.0026	0.00263	CcSEcCtD
Vildagliptin—Hyperhidrosis—Everolimus—kidney cancer	0.00259	0.00263	CcSEcCtD
Vildagliptin—Oedema—Erlotinib—kidney cancer	0.00259	0.00263	CcSEcCtD
Vildagliptin—Asthenia—Temsirolimus—kidney cancer	0.00259	0.00262	CcSEcCtD
Vildagliptin—Infection—Erlotinib—kidney cancer	0.00257	0.00261	CcSEcCtD
Vildagliptin—Nervous system disorder—Erlotinib—kidney cancer	0.00254	0.00257	CcSEcCtD
Vildagliptin—Skin disorder—Erlotinib—kidney cancer	0.00251	0.00255	CcSEcCtD
Vildagliptin—Angioedema—Sunitinib—kidney cancer	0.00251	0.00254	CcSEcCtD
Vildagliptin—Oedema peripheral—Gemcitabine—kidney cancer	0.00249	0.00253	CcSEcCtD
Vildagliptin—Connective tissue disorder—Gemcitabine—kidney cancer	0.00249	0.00252	CcSEcCtD
Vildagliptin—Diarrhoea—Temsirolimus—kidney cancer	0.00247	0.0025	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.00246	0.0025	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Everolimus—kidney cancer	0.00244	0.00248	CcSEcCtD
Vildagliptin—Asthenia—Pazopanib—kidney cancer	0.00244	0.00247	CcSEcCtD
Vildagliptin—Arthralgia—Sorafenib—kidney cancer	0.00243	0.00246	CcSEcCtD
Vildagliptin—Angiopathy—Vincristine—kidney cancer	0.00242	0.00246	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.00241	0.00245	CcSEcCtD
Vildagliptin—Weight increased—Paclitaxel—kidney cancer	0.00241	0.00244	CcSEcCtD
Vildagliptin—Dizziness—Temsirolimus—kidney cancer	0.00238	0.00242	CcSEcCtD
Vildagliptin—Infestation NOS—Paclitaxel—kidney cancer	0.00236	0.00239	CcSEcCtD
Vildagliptin—Infestation—Paclitaxel—kidney cancer	0.00236	0.00239	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00236	0.00239	CcSEcCtD
Vildagliptin—Arthralgia—Sunitinib—kidney cancer	0.00234	0.00237	CcSEcCtD
Vildagliptin—Diarrhoea—Pazopanib—kidney cancer	0.00232	0.00236	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.00232	0.00235	CcSEcCtD
Vildagliptin—Liver function test abnormal—Capecitabine—kidney cancer	0.00232	0.00235	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Everolimus—kidney cancer	0.00232	0.00235	CcSEcCtD
Vildagliptin—Infection—Sorafenib—kidney cancer	0.00231	0.00235	CcSEcCtD
Vildagliptin—Fatigue—Everolimus—kidney cancer	0.00231	0.00235	CcSEcCtD
Vildagliptin—Constipation—Vinblastine—kidney cancer	0.0023	0.00234	CcSEcCtD
Vildagliptin—Angiopathy—Gemcitabine—kidney cancer	0.0023	0.00233	CcSEcCtD
Vildagliptin—Constipation—Everolimus—kidney cancer	0.00229	0.00233	CcSEcCtD
Vildagliptin—Nervous system disorder—Sorafenib—kidney cancer	0.00228	0.00232	CcSEcCtD
Vildagliptin—Chills—Gemcitabine—kidney cancer	0.00227	0.0023	CcSEcCtD
Vildagliptin—Skin disorder—Sorafenib—kidney cancer	0.00226	0.00229	CcSEcCtD
Vildagliptin—Headache—Temsirolimus—kidney cancer	0.00226	0.00229	CcSEcCtD
Vildagliptin—Nasopharyngitis—Capecitabine—kidney cancer	0.00225	0.00228	CcSEcCtD
Vildagliptin—Dizziness—Pazopanib—kidney cancer	0.00225	0.00228	CcSEcCtD
Vildagliptin—Oedema—Sunitinib—kidney cancer	0.00224	0.00227	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00223	0.00227	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Paclitaxel—kidney cancer	0.00223	0.00226	CcSEcCtD
Vildagliptin—Fatigue—Erlotinib—kidney cancer	0.00223	0.00226	CcSEcCtD
Vildagliptin—Infection—Sunitinib—kidney cancer	0.00223	0.00226	CcSEcCtD
Vildagliptin—Constipation—Erlotinib—kidney cancer	0.00221	0.00225	CcSEcCtD
Vildagliptin—Nervous system disorder—Sunitinib—kidney cancer	0.0022	0.00223	CcSEcCtD
Vildagliptin—Skin disorder—Sunitinib—kidney cancer	0.00218	0.00221	CcSEcCtD
Vildagliptin—Nausea—Temsirolimus—kidney cancer	0.00214	0.00217	CcSEcCtD
Vildagliptin—Skin exfoliation—Doxorubicin—kidney cancer	0.00213	0.00216	CcSEcCtD
Vildagliptin—Headache—Pazopanib—kidney cancer	0.00213	0.00216	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00212	0.00215	CcSEcCtD
Vildagliptin—Oedema—Dactinomycin—kidney cancer	0.00212	0.00215	CcSEcCtD
Vildagliptin—Infection—Dactinomycin—kidney cancer	0.00211	0.00214	CcSEcCtD
Vildagliptin—Oedema peripheral—Paclitaxel—kidney cancer	0.00209	0.00212	CcSEcCtD
Vildagliptin—Connective tissue disorder—Paclitaxel—kidney cancer	0.00208	0.00211	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00204	0.00207	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Capecitabine—kidney cancer	0.00202	0.00205	CcSEcCtD
Vildagliptin—Nausea—Pazopanib—kidney cancer	0.00202	0.00205	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00201	0.00204	CcSEcCtD
Vildagliptin—Fatigue—Sorafenib—kidney cancer	0.00201	0.00204	CcSEcCtD
Vildagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—PAX6—kidney cancer	0.002	0.141	CbGpPWpGaD
Vildagliptin—Constipation—Sorafenib—kidney cancer	0.00199	0.00202	CcSEcCtD
Vildagliptin—Weight increased—Capecitabine—kidney cancer	0.00198	0.00201	CcSEcCtD
Vildagliptin—Infestation—Capecitabine—kidney cancer	0.00194	0.00196	CcSEcCtD
Vildagliptin—Infestation NOS—Capecitabine—kidney cancer	0.00194	0.00196	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00193	0.00196	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00193	0.00196	CcSEcCtD
Vildagliptin—Asthenia—Vinblastine—kidney cancer	0.00193	0.00196	CcSEcCtD
Vildagliptin—Fatigue—Sunitinib—kidney cancer	0.00193	0.00196	CcSEcCtD
Vildagliptin—Asthenia—Everolimus—kidney cancer	0.00192	0.00195	CcSEcCtD
Vildagliptin—Angiopathy—Paclitaxel—kidney cancer	0.00192	0.00195	CcSEcCtD
Vildagliptin—Constipation—Sunitinib—kidney cancer	0.00192	0.00194	CcSEcCtD
Vildagliptin—Chills—Paclitaxel—kidney cancer	0.0019	0.00193	CcSEcCtD
Vildagliptin—Oedema—Vincristine—kidney cancer	0.0019	0.00192	CcSEcCtD
Vildagliptin—Infection—Vincristine—kidney cancer	0.00188	0.00191	CcSEcCtD
Vildagliptin—Arthralgia—Gemcitabine—kidney cancer	0.00188	0.0019	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.00186	0.00189	CcSEcCtD
Vildagliptin—Nervous system disorder—Vincristine—kidney cancer	0.00186	0.00189	CcSEcCtD
Vildagliptin—Asthenia—Erlotinib—kidney cancer	0.00186	0.00188	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Doxorubicin—kidney cancer	0.00185	0.00188	CcSEcCtD
Vildagliptin—Urticaria—Sorafenib—kidney cancer	0.00185	0.00188	CcSEcCtD
Vildagliptin—Malnutrition—Paclitaxel—kidney cancer	0.00184	0.00187	CcSEcCtD
Vildagliptin—Diarrhoea—Vinblastine—kidney cancer	0.00184	0.00187	CcSEcCtD
Vildagliptin—Diarrhoea—Everolimus—kidney cancer	0.00184	0.00186	CcSEcCtD
Vildagliptin—Hyperhidrosis—Vincristine—kidney cancer	0.00183	0.00186	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Capecitabine—kidney cancer	0.00183	0.00186	CcSEcCtD
Vildagliptin—Fatigue—Dactinomycin—kidney cancer	0.00183	0.00186	CcSEcCtD
Vildagliptin—Flatulence—Paclitaxel—kidney cancer	0.00182	0.00184	CcSEcCtD
Vildagliptin—Oedema—Gemcitabine—kidney cancer	0.0018	0.00182	CcSEcCtD
Vildagliptin—Infection—Gemcitabine—kidney cancer	0.00179	0.00181	CcSEcCtD
Vildagliptin—Dizziness—Vinblastine—kidney cancer	0.00178	0.00181	CcSEcCtD
Vildagliptin—DPP4—Incretin synthesis, secretion, and inactivation—PAX6—kidney cancer	0.00178	0.126	CbGpPWpGaD
Vildagliptin—Dizziness—Everolimus—kidney cancer	0.00177	0.0018	CcSEcCtD
Vildagliptin—Diarrhoea—Erlotinib—kidney cancer	0.00177	0.0018	CcSEcCtD
Vildagliptin—Nervous system disorder—Gemcitabine—kidney cancer	0.00176	0.00179	CcSEcCtD
Vildagliptin—Skin disorder—Gemcitabine—kidney cancer	0.00175	0.00177	CcSEcCtD
Vildagliptin—Hepatitis—Capecitabine—kidney cancer	0.00174	0.00176	CcSEcCtD
Vildagliptin—Hyperhidrosis—Gemcitabine—kidney cancer	0.00174	0.00176	CcSEcCtD
Vildagliptin—Tremor—Paclitaxel—kidney cancer	0.00173	0.00175	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00173	0.00175	CcSEcCtD
Vildagliptin—Oedema peripheral—Capecitabine—kidney cancer	0.00171	0.00174	CcSEcCtD
Vildagliptin—Dizziness—Erlotinib—kidney cancer	0.00171	0.00174	CcSEcCtD
Vildagliptin—Connective tissue disorder—Capecitabine—kidney cancer	0.00171	0.00173	CcSEcCtD
Vildagliptin—Dermatitis bullous—Doxorubicin—kidney cancer	0.0017	0.00172	CcSEcCtD
Vildagliptin—Headache—Vinblastine—kidney cancer	0.00169	0.00171	CcSEcCtD
Vildagliptin—Angioedema—Paclitaxel—kidney cancer	0.00169	0.00171	CcSEcCtD
Vildagliptin—Headache—Everolimus—kidney cancer	0.00168	0.0017	CcSEcCtD
Vildagliptin—Asthenia—Sorafenib—kidney cancer	0.00167	0.00169	CcSEcCtD
Vildagliptin—Hypoglycaemia—Doxorubicin—kidney cancer	0.00166	0.00168	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00164	0.00166	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Vincristine—kidney cancer	0.00164	0.00166	CcSEcCtD
Vildagliptin—Fatigue—Vincristine—kidney cancer	0.00163	0.00166	CcSEcCtD
Vildagliptin—Headache—Erlotinib—kidney cancer	0.00162	0.00164	CcSEcCtD
Vildagliptin—Constipation—Vincristine—kidney cancer	0.00162	0.00164	CcSEcCtD
Vildagliptin—Asthenia—Sunitinib—kidney cancer	0.00161	0.00163	CcSEcCtD
Vildagliptin—Nausea—Vinblastine—kidney cancer	0.0016	0.00162	CcSEcCtD
Vildagliptin—Nausea—Everolimus—kidney cancer	0.00159	0.00162	CcSEcCtD
Vildagliptin—Diarrhoea—Sorafenib—kidney cancer	0.00159	0.00162	CcSEcCtD
Vildagliptin—Angiopathy—Capecitabine—kidney cancer	0.00158	0.0016	CcSEcCtD
Vildagliptin—Arthralgia—Paclitaxel—kidney cancer	0.00157	0.00159	CcSEcCtD
Vildagliptin—Chills—Capecitabine—kidney cancer	0.00156	0.00158	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00156	0.00158	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00155	0.00157	CcSEcCtD
Vildagliptin—Fatigue—Gemcitabine—kidney cancer	0.00155	0.00157	CcSEcCtD
Vildagliptin—Dizziness—Sorafenib—kidney cancer	0.00154	0.00156	CcSEcCtD
Vildagliptin—Constipation—Gemcitabine—kidney cancer	0.00154	0.00156	CcSEcCtD
Vildagliptin—Nausea—Erlotinib—kidney cancer	0.00154	0.00156	CcSEcCtD
Vildagliptin—Diarrhoea—Sunitinib—kidney cancer	0.00153	0.00156	CcSEcCtD
Vildagliptin—Asthenia—Dactinomycin—kidney cancer	0.00152	0.00154	CcSEcCtD
Vildagliptin—Malnutrition—Capecitabine—kidney cancer	0.00151	0.00154	CcSEcCtD
Vildagliptin—Oedema—Paclitaxel—kidney cancer	0.00151	0.00153	CcSEcCtD
Vildagliptin—Liver function test abnormal—Doxorubicin—kidney cancer	0.0015	0.00152	CcSEcCtD
Vildagliptin—Infection—Paclitaxel—kidney cancer	0.0015	0.00152	CcSEcCtD
Vildagliptin—Flatulence—Capecitabine—kidney cancer	0.00149	0.00151	CcSEcCtD
Vildagliptin—Dizziness—Sunitinib—kidney cancer	0.00148	0.0015	CcSEcCtD
Vildagliptin—Nervous system disorder—Paclitaxel—kidney cancer	0.00148	0.0015	CcSEcCtD
Vildagliptin—Skin disorder—Paclitaxel—kidney cancer	0.00146	0.00148	CcSEcCtD
Vildagliptin—Headache—Sorafenib—kidney cancer	0.00146	0.00148	CcSEcCtD
Vildagliptin—Hyperhidrosis—Paclitaxel—kidney cancer	0.00146	0.00148	CcSEcCtD
Vildagliptin—Diarrhoea—Dactinomycin—kidney cancer	0.00145	0.00147	CcSEcCtD
Vildagliptin—Nasopharyngitis—Doxorubicin—kidney cancer	0.00145	0.00147	CcSEcCtD
Vildagliptin—Tremor—Capecitabine—kidney cancer	0.00142	0.00144	CcSEcCtD
Vildagliptin—Headache—Sunitinib—kidney cancer	0.0014	0.00142	CcSEcCtD
Vildagliptin—Nausea—Sorafenib—kidney cancer	0.00138	0.0014	CcSEcCtD
Vildagliptin—Pancreatitis—Doxorubicin—kidney cancer	0.00137	0.00139	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00137	0.00139	CcSEcCtD
Vildagliptin—Asthenia—Vincristine—kidney cancer	0.00136	0.00138	CcSEcCtD
Vildagliptin—Nausea—Sunitinib—kidney cancer	0.00133	0.00135	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.0013	0.00132	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.0013	0.00132	CcSEcCtD
Vildagliptin—Fatigue—Paclitaxel—kidney cancer	0.0013	0.00132	CcSEcCtD
Vildagliptin—Diarrhoea—Vincristine—kidney cancer	0.0013	0.00132	CcSEcCtD
Vildagliptin—Asthenia—Gemcitabine—kidney cancer	0.00129	0.00131	CcSEcCtD
Vildagliptin—Arthralgia—Capecitabine—kidney cancer	0.00129	0.00131	CcSEcCtD
Vildagliptin—Constipation—Paclitaxel—kidney cancer	0.00129	0.00131	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00128	0.0013	CcSEcCtD
Vildagliptin—Weight increased—Doxorubicin—kidney cancer	0.00127	0.00129	CcSEcCtD
Vildagliptin—Nausea—Dactinomycin—kidney cancer	0.00126	0.00128	CcSEcCtD
Vildagliptin—Dizziness—Vincristine—kidney cancer	0.00125	0.00127	CcSEcCtD
Vildagliptin—Infestation NOS—Doxorubicin—kidney cancer	0.00125	0.00127	CcSEcCtD
Vildagliptin—Infestation—Doxorubicin—kidney cancer	0.00125	0.00127	CcSEcCtD
Vildagliptin—Oedema—Capecitabine—kidney cancer	0.00124	0.00125	CcSEcCtD
Vildagliptin—Diarrhoea—Gemcitabine—kidney cancer	0.00123	0.00125	CcSEcCtD
Vildagliptin—Infection—Capecitabine—kidney cancer	0.00123	0.00124	CcSEcCtD
Vildagliptin—Nervous system disorder—Capecitabine—kidney cancer	0.00121	0.00123	CcSEcCtD
Vildagliptin—Skin disorder—Capecitabine—kidney cancer	0.0012	0.00122	CcSEcCtD
Vildagliptin—Urticaria—Paclitaxel—kidney cancer	0.0012	0.00121	CcSEcCtD
Vildagliptin—Hyperhidrosis—Capecitabine—kidney cancer	0.00119	0.00121	CcSEcCtD
Vildagliptin—Headache—Vincristine—kidney cancer	0.00119	0.0012	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Doxorubicin—kidney cancer	0.00118	0.0012	CcSEcCtD
Vildagliptin—Headache—Gemcitabine—kidney cancer	0.00113	0.00114	CcSEcCtD
Vildagliptin—Nausea—Vincristine—kidney cancer	0.00113	0.00114	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.00113	0.00114	CcSEcCtD
Vildagliptin—Hepatitis—Doxorubicin—kidney cancer	0.00112	0.00114	CcSEcCtD
Vildagliptin—Oedema peripheral—Doxorubicin—kidney cancer	0.0011	0.00112	CcSEcCtD
Vildagliptin—Connective tissue disorder—Doxorubicin—kidney cancer	0.0011	0.00112	CcSEcCtD
Vildagliptin—Asthenia—Paclitaxel—kidney cancer	0.00108	0.0011	CcSEcCtD
Vildagliptin—Nausea—Gemcitabine—kidney cancer	0.00107	0.00108	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00107	0.00108	CcSEcCtD
Vildagliptin—Fatigue—Capecitabine—kidney cancer	0.00107	0.00108	CcSEcCtD
Vildagliptin—Constipation—Capecitabine—kidney cancer	0.00106	0.00107	CcSEcCtD
Vildagliptin—Diarrhoea—Paclitaxel—kidney cancer	0.00103	0.00104	CcSEcCtD
Vildagliptin—Angiopathy—Doxorubicin—kidney cancer	0.00102	0.00103	CcSEcCtD
Vildagliptin—Chills—Doxorubicin—kidney cancer	0.00101	0.00102	CcSEcCtD
Vildagliptin—Dizziness—Paclitaxel—kidney cancer	0.000995	0.00101	CcSEcCtD
Vildagliptin—Urticaria—Capecitabine—kidney cancer	0.000981	0.000995	CcSEcCtD
Vildagliptin—Malnutrition—Doxorubicin—kidney cancer	0.000976	0.00099	CcSEcCtD
Vildagliptin—Flatulence—Doxorubicin—kidney cancer	0.000961	0.000975	CcSEcCtD
Vildagliptin—Headache—Paclitaxel—kidney cancer	0.000943	0.000957	CcSEcCtD
Vildagliptin—Nausea—Paclitaxel—kidney cancer	0.000894	0.000907	CcSEcCtD
Vildagliptin—Asthenia—Capecitabine—kidney cancer	0.000886	0.000899	CcSEcCtD
Vildagliptin—Diarrhoea—Capecitabine—kidney cancer	0.000845	0.000857	CcSEcCtD
Vildagliptin—Arthralgia—Doxorubicin—kidney cancer	0.000831	0.000843	CcSEcCtD
Vildagliptin—DPP4—Peptide hormone metabolism—MME—kidney cancer	0.000827	0.0584	CbGpPWpGaD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000825	0.000837	CcSEcCtD
Vildagliptin—Dizziness—Capecitabine—kidney cancer	0.000817	0.000829	CcSEcCtD
Vildagliptin—Oedema—Doxorubicin—kidney cancer	0.000796	0.000808	CcSEcCtD
Vildagliptin—Infection—Doxorubicin—kidney cancer	0.000791	0.000802	CcSEcCtD
Vildagliptin—Nervous system disorder—Doxorubicin—kidney cancer	0.000781	0.000792	CcSEcCtD
Vildagliptin—Headache—Capecitabine—kidney cancer	0.000774	0.000785	CcSEcCtD
Vildagliptin—Skin disorder—Doxorubicin—kidney cancer	0.000773	0.000785	CcSEcCtD
Vildagliptin—Hyperhidrosis—Doxorubicin—kidney cancer	0.00077	0.000781	CcSEcCtD
Vildagliptin—Nausea—Capecitabine—kidney cancer	0.000734	0.000744	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000725	0.000736	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000687	0.000697	CcSEcCtD
Vildagliptin—Fatigue—Doxorubicin—kidney cancer	0.000687	0.000696	CcSEcCtD
Vildagliptin—Constipation—Doxorubicin—kidney cancer	0.000681	0.000691	CcSEcCtD
Vildagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CTNNB1—kidney cancer	0.000675	0.0477	CbGpPWpGaD
Vildagliptin—DPP4—Peptide hormone metabolism—ACHE—kidney cancer	0.000634	0.0448	CbGpPWpGaD
Vildagliptin—Urticaria—Doxorubicin—kidney cancer	0.000633	0.000642	CcSEcCtD
Vildagliptin—DPP4—Peptide hormone metabolism—PAX6—kidney cancer	0.000603	0.0426	CbGpPWpGaD
Vildagliptin—DPP4—Incretin synthesis, secretion, and inactivation—CTNNB1—kidney cancer	0.000601	0.0424	CbGpPWpGaD
Vildagliptin—DPP4—Peptide hormone metabolism—CTSD—kidney cancer	0.0006	0.0424	CbGpPWpGaD
Vildagliptin—Asthenia—Doxorubicin—kidney cancer	0.000571	0.00058	CcSEcCtD
Vildagliptin—DPP4—Peptide hormone metabolism—BCHE—kidney cancer	0.000552	0.039	CbGpPWpGaD
Vildagliptin—Diarrhoea—Doxorubicin—kidney cancer	0.000545	0.000553	CcSEcCtD
Vildagliptin—Dizziness—Doxorubicin—kidney cancer	0.000527	0.000534	CcSEcCtD
Vildagliptin—Headache—Doxorubicin—kidney cancer	0.000499	0.000506	CcSEcCtD
Vildagliptin—Nausea—Doxorubicin—kidney cancer	0.000473	0.00048	CcSEcCtD
Vildagliptin—DPP4—Metabolism of proteins—EIF5B—kidney cancer	0.000316	0.0223	CbGpPWpGaD
Vildagliptin—DPP4—Peptide hormone metabolism—POMC—kidney cancer	0.000285	0.0202	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—CUL7—kidney cancer	0.000282	0.0199	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—HSPA9—kidney cancer	0.000269	0.019	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—MUC4—kidney cancer	0.000219	0.0155	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—ST3GAL2—kidney cancer	0.000208	0.0147	CbGpPWpGaD
Vildagliptin—DPP4—Peptide hormone metabolism—CTNNB1—kidney cancer	0.000204	0.0144	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—EEF2—kidney cancer	0.000204	0.0144	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—MME—kidney cancer	0.000156	0.011	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—RPL14—kidney cancer	0.000145	0.0103	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—HSPD1—kidney cancer	0.000145	0.0103	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—ACHE—kidney cancer	0.00012	0.00846	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—EIF4EBP1—kidney cancer	0.000118	0.00836	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—PAX6—kidney cancer	0.000114	0.00805	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—CTSD—kidney cancer	0.000113	0.00801	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—BCHE—kidney cancer	0.000104	0.00737	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—IGF2—kidney cancer	8.07e-05	0.0057	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—POMC—kidney cancer	5.39e-05	0.00381	CbGpPWpGaD
Vildagliptin—DPP4—Metabolism of proteins—CTNNB1—kidney cancer	3.85e-05	0.00272	CbGpPWpGaD
